Longitudinal change in bone mineral density in a population-based cohort of patients with inflammatory bowel disease

Calcified Tissue International

Volumn 91, Issue 5, 2012, Pages 356-363

  Targownik, Laura E ^a   Leslie, William D ^a   Carr, Rachel ^a   Clara, Ian ^a   Miller, Norine ^a   Rogala, Linda ^a   Graff, Lesley A ^a,b   Walker, John R ^a,b   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Fracture; Inflammatory bowel disease; Osteoporosis

Indexed keywords

CORTICOSTEROID; PREDNISONE;

ADULT; AGE; ARTICLE; BODY MASS; BONE DENSITY; COHORT ANALYSIS; CROHN DISEASE; DISEASE ACTIVITY; DRUG USE; ENTERITIS; FEMALE; FEMUR NECK; FOOT FRACTURE; FOREARM FRACTURE; HIGH RISK PATIENT; HIP; HUMAN; LONGITUDINAL STUDY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SPINE FRACTURE; SPINE RADIOGRAPHY; ULCERATIVE COLITIS;

ADULT; BODY MASS INDEX; BONE DENSITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATORY BOWEL DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 84867578239     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-012-9650-1     Document Type: Article

References (31)

1. Bernstein CN (2006) Osteoporosis in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 4(2):152-156
2. Schoon EJ, van Nunen AB, Wouters RS, Stockbrugger RW, Russel MG (2000) Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort. Scand J Gastroenterol Suppl 232:43-47
3. Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK (1995) A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 37(1):71-76
4. Schulte C, Dignass AU, Mann K, Goebell H (1998) Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis 4(4): 268-275
5. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN (2000) The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 133(10):795-799
6. Tilg H, Moschen AR, Kaser A, Pines A, Dotan I (2008) Gut, inflammation and osteoporosis: basic and clinical concepts. Gut 57(5):684-694
7. van Hogezand RA, Hamdy NA (2006) Skeletal morbidity in inflammatory bowel disease. Scand J Gastroenterol Suppl 243: 59-64
8. Graff LA, Walker JR, Lix L, Clara I, Rawsthorne P, Rogala L, Miller N, Jakul L, McPhail C, Ediger J, Bernstein CN (2006) The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 4(12):1491-1501
9. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, Fedorak R, Israel D, Blanchard JF (2006) The epidemiology of inflammatory bowel disease in Canada: a population- based study. Am J Gastroenterol 101(7):1559-1568
10. Clara I, Lix LM, Walker JR, Graff LA, Miller N, Rogala L, Rawsthorne P, Bernstein CN (2009) The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity. Am J Gastroenterol 104(7):1754-1763
11. Harvey RF, Bradshaw JM (1980) A simple index of Crohn'sdisease activity. Lancet 1(8167):514
12. Powell-Tuck J, Bown RL, Lennard-Jones JE (1978) A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 13(7):833-837
13. Lewiecki EM, Watts NB, McClung MR, Petak SM, Bachrach LK, Shepherd JA, Downs RW Jr (2004) Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab 89(8):3651-3655
14. Jackson SA, Tenenhouse A, Robertson L (2000) Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 11(8):680-687
15. Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11(7): 984-996
16. Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse R, Kreiger N, Tenenhouse A, Goltzman D (2008) Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ 178(13): 1660-1668
17. Warming L, Hassager C, Christiansen C (2002) Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporos Int 13(2):105-112
18. Bainbridge KE, Sowers MF, Crutchfield M, Lin X, Jannausch M, Harlow SD (2002) Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am J Epidemiol 156(5):410-417
19. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C (1997) Reduced bone density in patients with inflammatory bowel disease. Gut 40(2):228-233
20. Jahnsen J, Falch JA, Mowinckel P, Aadland E (2004) Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Scand J Gastroenterol 39(2):145-153
21. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286(22): 2815-2822
22. Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham Study. J Bone Miner Res 8(5):567-573
23. van Staa TP (2006) The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 79(3):129-137
24. Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112(5): 352-364
25. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F (1995) Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 10(2):250-256
26. Bernstein CN, Leslie WD, Leboff MS (2003) AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124(3):795-841
27. van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK (2003) Inflammatory bowel disease and the risk of fracture. Gastroenterology 125(6):1591-1597
28. Ricanek P, Brackmann S, Perminow G, Lyckander LG, Sponheim J, Holme O, Hoie O, Rydning A, Vatn MH (2011) Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers. Scand J Gastroenterol 46(9):1081-1091
29. Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ (2008) Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 103(1):162-169
30. Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55(3): 426-431
31. Sipponen T, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Farkkila M (2008) Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 14(1): 40-46.